Company: KAVL
Filing Date: 2025-08-18
Form Type: 424B5
Source: 0001731122-25-001141
Chunk: 11

Company: Kaival Brands Innovations Group, Inc.
Filing Date: 2025-08-18
Form: 424B5
Chunk 11
---
 advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. |

We have taken advantage of certain reduced reporting
requirements in this prospectus. Accordingly, the information contained herein may be different than the information you receive from
other public companies in which you hold stock.

An emerging growth company can take advantage of the
extended transition period provided in Section 7(a)(2)(B) of the Securities Act for complying with new or revised accounting standards.
This allows an emerging growth company to delay the adoption of certain accounting standards until those standards would otherwise apply
to private companies. We have irrevocably elected to avail ourselves of this extended transition period and, as a result, we will not
be required to adopt new or revised accounting standards on the dates on which adoption of such standards is required for other public
reporting companies.

We are also a “smaller reporting company”
as defined in Rule 12b-2 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), and have elected
to take advantage of certain of the scaled disclosure available for smaller reporting companies.

<div align='center'>5

THE OFFERING</div>

| Issuer                                                                  | Kaival Brands Innovations Group, Inc.                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| Common stock to be offered by us pursuant to this prospectus supplement | 1,872,181shares of our common stock having an aggregate offering price of up to $1,553,536at an assumed offering price of $0.8298 per share, which was the last reported sale price of our common stock on the Nasdaq Capital Market on August 15, 2025.                                                                                                                                                                                                                                    |
| Common stock to be outstanding after the offering                       | Up to 13,414,483 shares of our common stock (as more fully described in the notes following this table), assuming sales of $1,553,536 of shares of our common stock, or 1,872,181 shares of our common stock in this offering at an assumed offering price of $0.8298 per share, which was the last reported sale price of our common stock on the Nasdaq Capital Market on August 15, 2025. The actual number of shares issued will vary depending on the sales price under this offering. |
| Plan of Distribution                                                    | “At the market offering” that may be made from time to time through Maxim, our sales agent. See the section entitled “Plan of Distribution.”                                                                                                                                                                                                                                                                                                                                                |
| Use